Clinical Trials Search Results

Results 1-10 of 114 for your search
Show Search Criteria
Tazemetostat in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 290 locations
Radiation Therapy with or without Cisplatin in Treating Patients with Recurrent Endometrial Cancer
Status: Active
Age: Not specified
Gender: Female
Location: 310 locations
Cabozantinib S-malate and Nivolumab in Treating Patients with Advanced, Recurrent or Metastatic Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 33 locations
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 18 locations
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 20 locations
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 14 locations
Phase 1 / 2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers
Status: Active
Age: 1 month and over
Gender: Male or Female
Location: 13 locations
1 2 3 ... 12 Next >